Why the study?
Does TEVAR yield different in-hospital mortality and 5-year survival outcomes in complicated versus uncomplicated type B aortic dissection?
Does TEVAR yield different in-hospital mortality and 5-year survival outcomes in complicated versus uncomplicated type B aortic dissection?
TEVAR provides comparable in-hospital mortality and 5-year survival for both complicated and uncomplicated type B aortic dissection, despite higher baseline comorbidities in complicated cases.
Supports TEVAR consideration for uncomplicated TBAD; extends meta-analytic evidence for equivalent outcomes across complexity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Howard et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: